Your Article Summary
See Latest ArticlesAmgen Introduces Neulasta FIRST STEP Program
Hill & Knowlton, 06/29/09
Amgen initiated the Neulasta FIRST STEP Program to provide assistance to eligible low income commercially-insured chemotherapy patients who need help affording their Neulasta co-insurance or co-payment requirement. The Neulasta FIRST STEP Program is the first medical benefit co-pay card in oncology and Amgen's latest addition to its long-standing patient assistance programs designed to meet the unique needs of each patient to help cover the cost of Amgen's medicines.
Today in Research & Development...keeping you current
Receive free subspecialty "5-minute updates" via email
New study results presented at 2009 san antonio breast cancer symposium show importance of protecting your bones
Amgen, 12/11/09
Salix Pharmaceuticals Reports Concurrence with FDA on Content and Format of the Pending Rifaximin NDA in the Treatment of Non-Constipation Irritable Bowel Syndrome
Salix Pharmaceuticals, 12/11/09